Abstract
In this paper we present the case of a female teenager patient who was diagnosed with bipolar affective disorder and during psychotropic treatment with risperidone, the prolactin levels ranged between 55 ng/mL and 85 ng/mL at monthly repeated dosing. During this period, the patient presented somatic alterations in her state of health. The patient benefited from brain imaging, which revealed that in sella turcica is distinguished a well-defined and relatively homogeneous formation, measuring approximately 11/8 mm, suggestive of a pituitary adenoma. After changing the antipsychotic treatment, the pituitary formation resolved to a subsequent imaging re-evaluation.
MeSH terms
-
Adolescent
-
Antipsychotic Agents / adverse effects*
-
Antipsychotic Agents / therapeutic use
-
Bipolar Disorder / complications
-
Bipolar Disorder / drug therapy*
-
Clomipramine / therapeutic use
-
Drug Substitution
-
Female
-
Haloperidol / therapeutic use
-
Humans
-
Hyperprolactinemia / chemically induced*
-
Magnetic Resonance Imaging
-
Neuroimaging
-
Olanzapine / therapeutic use
-
Pituitary Neoplasms / chemically induced*
-
Pituitary Neoplasms / complications
-
Pituitary Neoplasms / diagnostic imaging
-
Prolactin / blood
-
Prolactinoma / chemically induced*
-
Prolactinoma / complications
-
Prolactinoma / diagnostic imaging
-
Remission Induction
-
Risperidone / adverse effects*
-
Risperidone / therapeutic use
Substances
-
Antipsychotic Agents
-
Prolactin
-
Haloperidol
-
Risperidone
-
Olanzapine
-
Clomipramine